Splenectomy via the posterolateral approach in ovarian cancerLibing Xiang, Yulian Chen, Yixuan Liu, Zhihua Huang, Rongyu Zang
11 May 2023
European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023Maaike H M Oonk, François Planchamp, Peter Baldwin, Sven Mahner, Mansoor Raza Mirza, Daniela Fischerová, Carien L Creutzberg, Eugénie Guillot, Giorgia Garganese, Sigurd Lax, Andres Redondo, Alina Sturdza, Alexandra Taylor, Elena Ulrikh, Vincent VandecaveyeSee the full list of authors
27 June 2023
A prospective randomized controlled trial evaluating the safety and efficacy of patient blood management program in patients with gynecologic cancer (KGOG 4011/PBM)Jeong-Yeol Park, Ok Ju Kang, Yoo-Young Lee, Young Seok Kim
24 April 2023
Safety and management of niraparib monotherapy in ovarian cancer clinical trialsBradley J Monk, Antonio González-Martin, Lynn Buckley, Ursula A. Matulonis, B J Rimel, Xiaohua Wu, Kathleen N Moore, Mansoor R Mirza
15 February 2023
Impact of different post-operative treatment modalities on long-term outcomes in International Federation of Gynecology and Obstetrics (FIGO) 2018 stage IIICp cervical cancerAshvin Soochit, Chuyao Zhang, Yanling Feng, Xiaolin Luo, He Huang, Jihong Liu
31 March 2023
ESGO/ESTRO quality indicators for radiation therapy of cervical cancerCyrus Chargari, Kari Tanderup, François Planchamp, Luis Chiva, Pauline Humphrey, Alina Sturdza, Li T Tan, Elzbieta van der Steen-Banasik, Ignacio Zapardiel, Remi A Nout, Christina Fotopoulou
31 May 2023
TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocolMiranda P Steenbeek, Majke H D van Bommel, Joanna intHout, Christine B Peterson, Michiel Simons, Kit C B Roes, Marleen Kets, Barbara M Norquist, Elizabeth M Swisher, Rosella P M G Hermens, the TUBA-WISP II consortium, Karen H Lu, Joanne A de Hullu, the TUBA-WISP II consortium, Johan BultenSee the full list of authors
12 April 2023
Safety and activity of anti-mesothelin antibody–drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion studyAlessandro D Santin, Ignace Vergote, Antonio González-Martín, Kathleen Moore, Ana Oaknin, Ignacio Romero, Sami Diab, Larry J Copeland, Bradley J Monk, Robert L Coleman, Thomas J Herzog, Jonathan Siegel, Linda Kasten, Andreas Schlicker, Anke SchulzSee the full list of authors
23 December 2022
Quality assurance in human papillomavirus testing for primary cervical screeningKate Cuschieri, María Dolores Fellner, Laila Sara Arroyo Mühr, Elizaveta Padalko, Rita Mariel Correa, Joakim Dillner, Murat Gultekin, Maria Alejandra Picconi
13 March 2023
Transumbilical laparoendoscopic single-site radical trachelectomy with uterine arteries’ ascending branches preservation for early-stage cervical cancerYu Chen, Ying Zheng, Qiao Wang, Siyu Dai
16 December 2022